Cargando…

Anti-inflammation treatment for protection of hepatocytes and amelioration of hepatic fibrosis in rats

Chronic inflammation is considered as an important pathophysiologic mechanism of hepatic cirrhosis, which induces hepatocyte injury and activates hepatic stellate cells (HSCs), thus resulting in hepatic fibrosis. Previous studies have reported that cyclooxygenase-2 (COX-2) inhibitor can effectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Shi, Tong, Huan, Gao, Jin-Hang, Tang, Shi-Hang, Yang, Wen-Juan, Wang, Gui-Ming, Zhou, Hong-Ying, Wen, Shi-Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422404/ https://www.ncbi.nlm.nih.gov/pubmed/34584558 http://dx.doi.org/10.3892/etm.2021.10647

Ejemplares similares

Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis
por: Gao, Jin-Hang, et al.
Publicado: (2013)

Collapsed Reticular Network and its Possible Mechanism during the Initiation and/or Progression of Hepatic Fibrosis
por: Wen, Shi-Lei, et al.
Publicado: (2016)

Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2016)

Correction: Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2022)

Suppression of CB1 Cannabinoid Receptor by Lentivirus Mediated Small Interfering RNA Ameliorates Hepatic Fibrosis in Rats
por: Chen, Si-Wen, et al.
Publicado: (2012)

Interaction of non-parenchymal hepatocytes in the process of hepatic fibrosis
por: Cheng, Qi-Ni, et al.
Publicado: (2021)

Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats
por: Su, Wei, et al.
Publicado: (2020)

Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
por: Albadawy, Reda, et al.
Publicado: (2022)

Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile acid metabolism and hepatocyte pyroptosis in male mice
por: Zhao, Qi, et al.
Publicado: (2023)

Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
por: Guo, Ren, et al.
Publicado: (2022)

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model
por: Yu, Li-Ya, et al.
Publicado: (2017)

Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation
por: TONG, HUAN, et al.
Publicado: (2013)

Epigallocatechin-3-gallate ameliorates LPS-induced inflammation by inhibiting the phosphorylation of Akt and ERK signaling molecules in rat H9c2 cells
por: Li, Zhi Hui, et al.
Publicado: (2020)

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
por: Zhang, Kun, et al.
Publicado: (2019)

Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride
por: Tang, Shi-Hang, et al.
Publicado: (2017)

Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation
por: Yu, Yingxue, et al.
Publicado: (2016)

Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats
por: Ohara, Masatsugu, et al.
Publicado: (2018)

Aggravated hepatic fibrosis induced by phenylalanine and tyrosine was ameliorated by chitooligosaccharides supplementation
por: Liu, Peng, et al.
Publicado: (2023)

MiR-21 Simultaneously Regulates ERK1 Signaling in HSC Activation and Hepatocyte EMT in Hepatic Fibrosis
por: Zhao, Juan, et al.
Publicado: (2014)

FOXA2 alleviates CCl(4)-induced liver fibrosis by protecting hepatocytes in mice
por: Wang, Wei, et al.
Publicado: (2017)

Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation
por: Peng, Ling, et al.
Publicado: (2020)

Transplantation of bone marrow-derived endothelial progenitor cells and hepatocyte stem cells from liver fibrosis rats ameliorates liver fibrosis
por: Lan, Ling, et al.
Publicado: (2018)

Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism
por: Gracia‐Sancho, Jordi, et al.
Publicado: (2019)

Augmenter of liver regeneration ameliorates renal fibrosis in rats with obstructive nephropathy
por: Chen, Guo-tao, et al.
Publicado: (2014)

Hepatic and portal vein Doppler ultrasounds in assessing liver inflammation and fibrosis in chronic HBV infection with a normal ALT level
por: Tian, Li, et al.
Publicado: (2023)

New anti-diabetic drug Morus alba L. (Sangzhi) alkaloids (SZ-A) improves diabetic nephropathy through ameliorating inflammation and fibrosis in diabetic rats
por: Li, Caina, et al.
Publicado: (2023)

Protective/preventive effects of quercetin against cyclophosphamide-induced hepatic inflammation, apoptosis and fibrosis in rats
por: Turedi, Sibel
Publicado: (2023)

Etanercept Ameliorates Cardiac Fibrosis in Rats with Diet-Induced Obesity
por: Hsu, Chia-Chen, et al.
Publicado: (2021)

Protective Effect of Qingchang Wenzhong Decoction on Colitis and Colitis-Related Carcinogenesis by Regulating Inflammation and Intestinal Fibrosis
por: Cheng, Yuan, et al.
Publicado: (2023)

Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats
por: Chen, Huanjie, et al.
Publicado: (2023)

CBGA ameliorates inflammation and fibrosis in nephropathy
por: Suzuki, Sayuri, et al.
Publicado: (2023)

Loss of hepatocyte cell division leads to liver inflammation and fibrosis
por: Dewhurst, Matthew R., et al.
Publicado: (2020)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Liver Fibrosis and Protection Mechanisms Action of Medicinal Plants Targeting Apoptosis of Hepatocytes and Hepatic Stellate Cells
por: Duval, Florent, et al.
Publicado: (2014)

Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes
por: Zhang, Xiao-Wei, et al.
Publicado: (2016)

Blocking GSDMD processing in innate immune cells but not in hepatocytes protects hepatic ischemia–reperfusion injury
por: Li, Jichang, et al.
Publicado: (2020)

Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice
por: Zheng, Han, et al.
Publicado: (2018)

Eicosapentaenoic Acid Ameliorates Cardiac Fibrosis and Tissue Inflammation in Spontaneously Hypertensive Rats
por: Gharraee, Nazli, et al.
Publicado: (2022)

Stem cells from human exfoliated deciduous teeth ameliorate concanavalin A-induced autoimmune hepatitis by protecting hepatocytes from apoptosis
por: Zhou, Yi-Kun, et al.
Publicado: (2020)

Protective effects of crude chalaza hydrolysates against liver fibrogenesis via antioxidation, anti-inflammation/anti-fibrogenesis, and apoptosis promotion of damaged hepatocytes
por: Lin, Yi-Ling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oidmh6lkafm4bdc0rs4f69siah